Vikram Kapur
Partner,
Head of our Global Healthcare & Life Sciences practice
Vikram
専門分野
Highlights
- Member of Bain's Global Compensation and Promotion committee
- Leads Bain's Global Senior Manager training program
Vikram Kapur is the head of our Global Healthcare & Life Sciences practice, as well as our APAC Healthcare practice. Within healthcare, he primarily advises clients in the services, medical technology, biopharma and payer and provider healthcare sectors, with additional expertise in healthcare private equity transactions.
He has more than 20+ years of management consulting and operating experience delivering strategies that work for change-oriented business leaders across the Americas, Europe and APAC.
Vikram holds deep expertise in strategy development, operational improvement, acquisition due diligence and complex cross-border M&A and integration efforts.
He is recognized as a thought leader in the industry and is very active in key industry forums both in the region and globally.
Vikram joined Bain's Chicago office in 2001 and, in addition to Singapore, has spent time working in Bain's Dallas, Stockholm, New York and Hong Kong offices.
Vikram received an MBA at the Wharton School at the University of Pennsylvania, an MS in industrial engineering from Northwestern University and a BS in electrical engineering from Case Western Reserve University.
Recent Insights
- “Who Do Asia-Pacific Consumers Trust to Manage Their Healthcare?,” スナップチャート, 2024年6月11日
- “Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint,” スナップチャート, 2024年5月29日
- “Asia-Pacific Telemedicine Is Here to Stay,” スナップチャート, 2024年5月15日
- “Inside Bain's 2024 Asia-Pacific Front Line of Healthcare Report,” Webinar, 2024年4月24日
- “Asia-Pacific Front Line of Healthcare 2024,” レポート, 2024年4月3日
In the News
- “Bain & Company appoints Vikram Kapur to lead its global Healthcare & Life Sciences practice,” Press release, 2024年7月10日
- “Asia-Pacific consumers, especially Gen Z, are taking greater ownership in health and well-being, Bain survey finds,” Press release, 2024年4月2日
- “Majority of Asia Pacific medtech companies and customers have set ESG metrics, survey ,” Press release, 2023年10月24日
- “China’s healthcare deals struggle, but M&As expected to drive growth,” Deal Street Asia, 2023年4月20日, Deal Street Asia
- “Healthcare private equity deals rise in Asia-Pacific thanks to funds’ plentiful ‘dry powder’, strong demand: Bain & Co,” South China Morning Post, 2023年4月11日, South China Morning Post